Human Velosulin

What is it?

A preparation of short-acting, human insulin comprising neutral, soluble human insulin (pyr) which is highly purified, 100iu per ml, available in vials for injection.

Medical Uses

Diabetes.

Dosage

According to individual patient requirements; usually self-delivered by bolus subcutaneous, intramuscular or intravenous injection or, by subcutaneous infusion into the abdominal wall using an insulin infusion pump. Dosages are less if patient is changing from injection to infusion delivery, effects last for about 8 hours.

Special Care

Kidney or liver disease, patients transferring from animal insulins (should be warned that early signs of hypoglycaemia may not be so apparent). Infections, illnesses, stress, emotional upset, pregnancy, change in insulin source, type etc; in all these cases, dose adjustments may be needed.

Possible Drug and Food Interactions

Oral contraceptives, MAOIs, alcohol, β-blockers, corticotrophin, diuretics, corticosteroids.

Known Side Effects

Lipodystrophy (changes involving fat deposition) at injection site.

Manufacturer

Novo Nordisk